Comparison of TAK-875 (Fasiglifam) With Placebo in Participants With Type 2 Diabetes

NCT01456195 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

421

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: Placebo
DRUG: Fasiglifam

Sponsor

Takeda